Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Disovery of Novel Mutations Exclusively Shared By Accelerated and Blast Crisis Phase CML Patients Using Whole Exome Sequencing:Implication in Hunt for Common Biomarker /Drug Target of CML Progression

Zafar Iqbal, MPhil PhD, Salman Basit, PhD, Abid Jamil, MDPhD, Muhammad Absar, Anhar Ullah, MS, Sibtain Afzal, Aamer Mahmood, PhD, Khushnooda Ramzan, PhD, Aamir Aleem, Jamil Amjad Hashmi, Noor Rehman, Khalid Aljamaan, Saleh Aloraibi, Giuseppe Saglio, MD PhD, Nawaf Alanazi, Mudassar Iqbal, MDMS, Tanveer Akhtar

Blood (2017) 130 (Supplement 1): 2886.

https://doi.org/10.1182/blood.V130.Suppl_1.2886.2886

Published: 2017

Journal Articles

Drug Transporters in Imatinib Resistance: A New Therapeutic Targeted Approach In CML

Raquel Alves, MSc student, Raquel Fonseca, MSc student, Ana Cristina Gonçalves, MSc, PhD student, Vera Alves, BSc, Ana Margarida Abrantes, MSc, PhD student, Filomena Botelho, MD, PhD, Ana Bela Sarmento-Ribeiro, MD, PhD

Blood (2011) 118 (21): 5010.

https://doi.org/10.1182/blood.V118.21.5010.5010

Published: 2011

Journal Articles

Transcriptome of Expressed Genes in CD34+ and CD66b+ Chronic Myeloid Leukemia Cells and Its Potential Role in the Transport of Kinase Inhibitors

Caroline Fátima Aquino Moreira-Nnes, MsC, Ana Cristina Simões Beltrão, MD, MSc, Tereza Cristina Brito Azevedo, MD, MSc, Larissa Tatiana Valente Martins Francês, MD, MSc, Rodrigo Guarischi Mattos Amaral Sousa, MSc, Israel Tojal Silva, PhD, Artur Luiz Costa Silva, PhD, Wilson Araújo Silva-Jr, PhD, José Alexandre Rodrigues Lemos, PhD

Blood (2011) 118 (21): 4426.

https://doi.org/10.1182/blood.V118.21.4426.4426

Published: 2011

Journal Articles

Identification of A Pharmacogenomic Profile Associated with High Sensitivity and Low Toxicity to a Combination of Gemtuzumab Ozogamicin Plus Fludarabine, Cytarabine, Idarubicin Regimen In CD33-Positive Acute Myeloid Leukemia (AML) Patients

Blood (2010) 116 (21): 967.

https://doi.org/10.1182/blood.V116.21.967.967

Published: 2010

Journal Articles

Movement of Hydroxyurea Across Cell Membranes Is Mediated by Specific Solute Carrier (SLC) Transporters.

Aisha L. Walker, PhD, Ryan M Franke, PhD, Alex Sparreboom, PhD, Russell E. Ware, MD, PhD

Blood (2009) 114 (22): 2575.

https://doi.org/10.1182/blood.V114.22.2575.2575

Published: 2009

Journal Articles

Imatinib Mesylate Induced Reversal of Leukemic Gene Phenotype in HL60 Cells Coincides with Stimulation of Oxidative Metabolism.

Michael Pfeilstocker, MD, Peter Wihlidal, MSc, Franz Varga, PhD, Elisabeth Pittermann, MD, Heidrun Karlic, PhD

Blood (2007) 110 (11): 4190.

https://doi.org/10.1182/blood.V110.11.4190.4190

Published: 2007

Journal Articles

Hypermethylation and Reduced Carnitine Availability - Possible Mechanisms for Downregulation of Microsomal Carnitine Palmitoyltransferase (mCPT) in Myelodysplastic Syndromes (MDS).

Michael Pfeilstocker, MD, Heidrun Karlic, PhD, Peter Wihlidal, Thomas Noesslinger, MD, Elisabeth Pittermann, MD

Blood (2006) 108 (11): 2648.

https://doi.org/10.1182/blood.V108.11.2648.2648

Published: 2006

NARROW

Disovery of Novel Mutations Exclusively Shared By Accelerated and Blast Crisis Phase CML Patients Using Whole Exome Sequencing:Implication in Hunt for Common Biomarker /Drug Target of CML Progression

Drug Transporters in Imatinib Resistance: A New Therapeutic Targeted Approach In CML

Transcriptome of Expressed Genes in CD34+ and CD66b+ Chronic Myeloid Leukemia Cells and Its Potential Role in the Transport of Kinase Inhibitors

Identification of A Pharmacogenomic Profile Associated with High Sensitivity and Low Toxicity to a Combination of Gemtuzumab Ozogamicin Plus Fludarabine, Cytarabine, Idarubicin Regimen In CD33-Positive Acute Myeloid Leukemia (AML) Patients

Movement of Hydroxyurea Across Cell Membranes Is Mediated by Specific Solute Carrier (SLC) Transporters.

Imatinib Mesylate Induced Reversal of Leukemic Gene Phenotype in HL60 Cells Coincides with Stimulation of Oxidative Metabolism.

Hypermethylation and Reduced Carnitine Availability - Possible Mechanisms for Downregulation of Microsomal Carnitine Palmitoyltransferase (mCPT) in Myelodysplastic Syndromes (MDS).

Email alerts

ASH Publications

American Society of Hematology

Disovery of Novel Mutations Exclusively Shared By Accelerated and Blast Crisis Phase CML Patients Using Whole Exome Sequencing:Implication in Hunt for Common Biomarker /Drug Target of CML Progression

Drug Transporters in Imatinib Resistance: A New Therapeutic Targeted Approach In CML

Transcriptome of Expressed Genes in CD34+ and CD66b+ Chronic Myeloid Leukemia Cells and Its Potential Role in the Transport of Kinase Inhibitors

Identification of A Pharmacogenomic Profile Associated with High Sensitivity and Low Toxicity to a Combination of Gemtuzumab Ozogamicin Plus Fludarabine, Cytarabine, Idarubicin Regimen In CD33-Positive Acute Myeloid Leukemia (AML) Patients

Movement of Hydroxyurea Across Cell Membranes Is Mediated by Specific Solute Carrier (SLC) Transporters.

Imatinib Mesylate Induced Reversal of Leukemic Gene Phenotype in HL60 Cells Coincides with Stimulation of Oxidative Metabolism.

Hypermethylation and Reduced Carnitine Availability - Possible Mechanisms for Downregulation of Microsomal Carnitine Palmitoyltransferase (mCPT) in Myelodysplastic Syndromes (MDS).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only